HNWAG
IRWD icon

High Net Worth Advisory Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

High Net Worth Advisory Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-500
Closed -$6K – 695
2022
Q1 		$6K Buy
+500
New +$5.73K ﹤0.01% 579

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

High Net Worth Advisory Group's IRWD Position: Q2 2022 in Review

High Net Worth Advisory Group sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 500 shares — an estimated $6K sold.

High Net Worth Advisory Group first reported a position in IRWD in Q1 2022 and held it in 1 quarter. The position peaked at $6K in Q1 2022. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

  • High Net Worth Advisory Group reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • High Net Worth Advisory Group sold 500 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $6K.
  • High Net Worth Advisory Group first reported a position in Ironwood Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • High Net Worth Advisory Group's Ironwood Pharmaceuticals position peaked at $6K in Q1 2022.
  • 239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on High Net Worth Advisory Group's 13F filing for Q2 2022, filed 10 Aug 2022.